Windtree Therapeutics Inc (WINT) Stock Price, Quote & News

Company Profile

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infan...

Industry: Biotechnology

Sector: Healthcare

Phone: 215 488 9300

Website: windtreetx.com

Address:

2600 Kelly Road, Suite 100, Warrington, United States

EverythingIBuyPumpsHuge Aug. 16 at 9:27 AM

$WINT same development as $DRUG - whoever sold will regret until the rest of their lives https://fintel.io/topic/what-is-the-markets-opinion-on-drug-86-4286

1 · Reply

justiceforb_85 Aug. 16 at 4:43 AM

$WINT yikes! When is the reverse split?

1 · Reply

luke_belmar Aug. 16 at 3:28 AM

$WINT Ain't Dead, It's Just Loading.....Binance Treasury Meets Biotech Breakthrough.$WINT just lined up a $500 million line of credit from Build and Build Co, that's on top of the earlier $200M deal. We're talking $700M total to buy Binance Coin for their treasury, with Kraken on deck to handle custody and OTC. Yeah, Kraken, not some back-alley operation. They're building a Binance vault while Wall Street's still playing with crayons.

1 · Reply

deniz100 Aug. 15 at 4:59 PM

$WINT Still not $70?

3 · Reply

Mike827 Aug. 15 at 3:38 PM

$WINT what happened to the bnb treasury 🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️

0 · Reply

payitforwardx2 Aug. 15 at 2:43 PM

$WINT 5150. Could get 🤪 crazy

0 · Reply

EverythingIBuyPumpsHuge Aug. 15 at 2:04 PM

$WINT very bullish - check the news

0 · Reply

EverythingIBuyPumpsHuge Aug. 15 at 1:55 PM

$WINT block and report this retard

1 · Reply

klauds Aug. 15 at 1:23 PM

$CVNA $HKD $WINT As of today, I’m blocking this mad dog. This person has a notorious reputation across countless communities. Even without my warning, I doubt anyone with a shred of sense would believe anything they post. If you look at their recent posts, they’re still shouting “buy” on stocks that have dropped 99%. Truly a pathetic human being. I’ll be blocking this person now and leaving.

0 · Reply

Popeye989 Aug. 15 at 11:50 AM

$WINT lol this board has changed.. Well, I’ve popped in to warn everyone. Glad everyone is starting to realize this is horrible :) happy Friday!

0 · Reply

Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025

Jul 29, 2025, 9:01 AM EDT - 18 days ago

Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

Jul 24, 2025, 9:00 AM EDT - 23 days ago

Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy

Jul 16, 2025, 9:22 AM EDT - 4 weeks ago

Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions

Jul 2, 2025, 9:00 AM EDT - 6 weeks ago

Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure

Jun 26, 2025, 4:05 PM EDT - 7 weeks ago

Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel

May 22, 2025, 8:16 AM EDT - 3 months ago

Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

May 12, 2025, 8:00 AM EDT - 3 months ago

Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025

May 6, 2025, 8:18 AM EDT - 3 months ago

Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US

Mar 26, 2025, 8:47 AM EDT - 5 months ago

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

Mar 24, 2025, 8:30 AM EDT - 5 months ago

Evofem Reports Fourth Consecutive Year of Net Sales Growth

ADTX

Mar 24, 2025, 8:00 AM EDT - 5 months ago

Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules

Mar 20, 2025, 8:00 AM EDT - 5 months ago

Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product

Jan 15, 2025, 8:00 AM EST - 7 months ago

Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company's Oncology Pipeline

Jan 13, 2025, 8:00 AM EST - 7 months ago

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

Dec 9, 2024, 8:00 AM EST - 8 months ago

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

Dec 4, 2024, 8:00 AM EST - 9 months ago

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

Nov 27, 2024, 4:05 PM EST - 9 months ago

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

Oct 23, 2024, 8:00 AM EDT - 10 months ago

Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World

Oct 17, 2024, 8:15 AM EDT - 10 months ago

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan

Sep 30, 2024, 8:15 AM EDT - 11 months ago

Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock

Sep 26, 2024, 4:05 PM EDT - 11 months ago

Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET

Sep 25, 2024, 8:15 AM EDT - 11 months ago

Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock

Aug 20, 2024, 4:05 PM EDT - 1 year ago

Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Windtree Announces New Additions and Changes to Its Board of Directors

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data

May 7, 2024, 8:00 AM EDT - 1 year ago

Windtree Therapeutics Regains Compliance with Nasdaq

Apr 22, 2024, 11:06 AM EDT - 1 year ago

What made Windtree Therapeutics stock tank 20% on Monday?

Apr 18, 2024, 8:00 AM EDT - 1 year ago

Windtree Therapeutics Announces Reverse Stock Split

Apr 17, 2024, 8:00 AM EDT - 1 year ago

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Apr 8, 2024, 4:48 PM EDT - 1 year ago

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

Feb 1, 2024, 8:00 AM EST - 1 year ago

Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research

Jan 31, 2024, 8:00 AM EST - 1 year ago

Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives

Jan 26, 2024, 9:20 AM EST - 1 year ago

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

Jan 25, 2024, 8:30 AM EST - 1 year ago

Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company

Jan 18, 2024, 9:00 AM EST - 1 year ago

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China

Jan 17, 2024, 8:00 AM EST - 1 year ago

Windtree Therapeutics Announces License Agreement with Lee's Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region

Jan 2, 2024, 4:05 PM EST - 1 year ago

Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator

Dec 19, 2023, 9:30 AM EST - 1 year ago

Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024

Dec 18, 2023, 8:00 AM EST - 1 year ago

Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock

Nov 16, 2023, 8:00 AM EST - 1 year ago

Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator Patent

Nov 9, 2023, 4:15 PM EST - 1 year ago

Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates

Nov 8, 2023, 8:00 AM EST - 1 year ago

Windtree to Present at the Sidoti Micro Cap Conference on November 16th

Oct 12, 2023, 7:30 AM EDT - 2 years ago

Windtree to Present at the ThinkEquity Conference on October 19th in New York City

Oct 10, 2023, 7:30 AM EDT - 2 years ago

Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th

Oct 3, 2023, 8:00 AM EDT - 2 years ago

Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th

Aug 23, 2023, 8:00 AM EDT - 2 years ago

Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office

Aug 16, 2023, 9:00 AM EDT - 2 years ago

Windtree Therapeutics (NASDAQ:WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market

Aug 7, 2023, 4:05 PM EDT - 2 years ago

Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates

Jul 25, 2023, 9:25 AM EDT - 2 years ago

Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure

EverythingIBuyPumpsHuge Aug. 16 at 9:27 AM

$WINT same development as $DRUG - whoever sold will regret until the rest of their lives https://fintel.io/topic/what-is-the-markets-opinion-on-drug-86-4286

1 · Reply

justiceforb_85 Aug. 16 at 4:43 AM

$WINT yikes! When is the reverse split?

1 · Reply

luke_belmar Aug. 16 at 3:28 AM

1 · Reply

deniz100 Aug. 15 at 4:59 PM

$WINT Still not $70?

3 · Reply

Mike827 Aug. 15 at 3:38 PM

$WINT what happened to the bnb treasury 🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️

0 · Reply

payitforwardx2 Aug. 15 at 2:43 PM

$WINT 5150. Could get 🤪 crazy

0 · Reply

EverythingIBuyPumpsHuge Aug. 15 at 2:04 PM

$WINT very bullish - check the news

0 · Reply

EverythingIBuyPumpsHuge Aug. 15 at 1:55 PM

$WINT block and report this retard

1 · Reply

klauds Aug. 15 at 1:23 PM

0 · Reply

Popeye989 Aug. 15 at 11:50 AM

$WINT lol this board has changed.. Well, I’ve popped in to warn everyone. Glad everyone is starting to realize this is horrible :) happy Friday!

0 · Reply

Mike827 Aug. 15 at 5:39 AM

$WINT

0 · Reply

EverythingIBuyPumpsHuge Aug. 14 at 7:52 PM

$WINT I’ve noticed that some of these short sellers, including @klauds, appear to be based in regions like China or Korea. Their activity drops off completely after certain hours, which suggests a geographic pattern. They tend to be very aggressive in their approach, but their strategy often seems shortsighted compared to North American traders, very low IQ I would say . I think running this after-hours could catch them off guard when they return. They also tend to be very active during pre-market sessions.

2 · Reply

EverythingIBuyPumpsHuge Aug. 14 at 7:23 PM

$WINT such news ====> can bring any stock to 1000% profit run. We need to exterminate these short rats $CVNA $HKD

0 · Reply

EverythingIBuyPumpsHuge Aug. 14 at 7:03 PM

$WINT

0 · Reply

Mike827 Aug. 14 at 6:52 PM

$WINT bnb crypto treasury must have been a scam 🤔

1 · Reply

Mike827 Aug. 14 at 6:51 PM

$WINT absolutely no institutional investors will touch this stock with management begging shareholders to approve a reverse split. it will never go up🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️🤷🏿‍♀️

1 · Reply

Scoooter Aug. 14 at 6:30 PM

$AERT I see these $1 stocks go up 650% every day This is up .32 so far and looks like a multi day runner Should pop up fast in AH And gap up in the AM Watched this happen on $WINT multiple times

1 · Reply

Scoooter Aug. 14 at 6:15 PM

$AERT See It’s up .36 now It’s gonna run up into close and go to $1.53 in after hours Then a gap up tomorrow Like $WINT did in the past

0 · Reply

Scoooter Aug. 14 at 5:52 PM

$AERT Reminds me of $WINT Went below a buck Only to go up to almost $4.00 in after hours and the next day

0 · Reply

klauds Aug. 14 at 4:28 PM

$WINT

0 · Reply

EverythingIBuyPumpsHuge Aug. 14 at 4:24 PM

$WINT shorts are slowly buying : so do I

1 · Reply

klauds Aug. 14 at 4:19 PM

$WINT The stock you bought was at $1.50, and now it’s at $0.50. Even if it goes up 100% and reaches $1.00, you’re still down by $0.50. Do you really think cheering for a 100% gain makes sense when you’re still at a loss? You just look like a fool blindly praising it.

0 · Reply

Market Cap	1.88M
Revenue (ttm)	0.00
Net Income (ttm)	-1.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.05

Volume	798,000
Avg Vol	13,785,110
Day's Range	N/A - N/A
Shares Out	3.66M
Stochastic %K	11%
Beta	0.63
Analysts	Strong Buy
Price Target	$4.00